药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Benoxaprofen
Benoxaprofen may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Nimesulide
Nimesulide may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Latamoxef
Latamoxef may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Cephalothin Group
Cephalothin Group may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Hydrolyzed Cephalothin
Hydrolyzed Cephalothin may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Etoricoxib
Etoricoxib may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Tiaprofenic acid
Tiaprofenic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Antrafenine
Antrafenine may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Cefpodoxime
Cefpodoxime may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Choline magnesium trisalicylate
Choline magnesium trisalicylate may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Salsalate
Salsalate may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Magnesium salicylate
Magnesium salicylate may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Cefoxitin
Cefoxitin may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Cefotetan
Cefotetan may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Cefonicid
Cefonicid may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Pirbuterol
Gallopamil
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Gallopamil.
Pirbuterol
Lidoflazine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lidoflazine.
Pirbuterol
Bencyclane
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bencyclane.
Pirbuterol
Ebastine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ebastine.
Pirbuterol
Aranidipine
The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Aranidipine.